Table 4 Comparison of the characteristics and variables in families with and without additional cases of uterine cancer

Age (years)

65

(36,9)

67

(35,0)

0.082 (Wilcoxon rank sum test)

Body mass index

26.6

(17.6,43.4)

26.2

(17.7,55.1)

0.466 (Wilcoxon rank sum test)

number

row percent

number

row percent

Histology

Endometrioid

52

(81%)

342

(82%)

0.102 (chi.sq test)

Serous or mixed

4

(6%)

52

(12%)

Clear cell

3

(5%)

6

(1%)

Sarcoma

5

(8%)

15

(4%)

Hyperplasia

0

(0%)

2

(0%)

FIGO stage

1A

45

(70%)

271

(65%)

0.367 (chi.sq test)

1B

11

(17%)

84

(20%)

2

2

(3%)

32

(8%)

3A

4

(6%)

12

(3%)

3B

0

(0%)

7

(2%)

3C

0

(0%)

2

(0%)

4

0

(0%)

3

(1%)

4B

2

(3%)

5

(1%)

Relapse

No

61

(95%)

403

(97%)

0.726 (chi.sq test)

Yes

3

(5%)

14

(3%)

Ploidy

Aneuploid

13

(22%)

108

(28%)

0.338 (chi.sq test)

Diploid

47

(78%)

274

(72%)

Multiple cancers

No

52

(81%)

354

(85%)

0.478 (chi.sq test)

Yes

12

(19%)

63

(15%)

Uterine cancer <50 years of age

No

57

(89%)

389

(93%)

0.300 (chi.sq test)

Yes

7

(11%)

28

(7%)

Relative with cancer <50 years of age

No

34

(53%)

310

(74%)

0.001 (chi.sq test)

Yes

30

(47%)

107

(26%)